Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50228-151

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50228-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Valsartan01)

A line graph depicting the percentage of patients achieving systolic blood pressure (SBP) below 140 mmHg, plotted against baseline SBP values ranging from 140 to 180 mmHg. Four treatment groups are compared: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The graph shows how effectiveness varies across baseline SBP levels for each group.*

FDA Label Image

Figure2 (Valsartan02)

A line graph showing the percentage of DBP<90 mmHg against baseline DBP (mmHg) for four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The graph compares blood pressure outcomes across these treatments.*

FDA Label Image

Figure3 (Valsartan03)

A line graph showing the percentage of patients achieving systolic blood pressure (SBP) below 130 mmHg against baseline SBP values ranging from 140 to 180 mmHg. Four data series compare valsartan HCT 320/25 mg, valsartan 320 mg, hydrochlorothiazide 25 mg, and placebo. The graph displays treatment effectiveness based on baseline SBP measurements.*

FDA Label Image

Figure4 (Valsartan04)

A line graph depicting the percentage of patients achieving diastolic blood pressure (DBP) less than 80 mmHg versus baseline DBP values between 90 and 110 mmHg. The graph compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating their effects on DBP reduction.*

FDA Label Image

Figure5 (Valsartan05)

Chemical structure of valsartan showing its molecular composition and arrangement of atoms.*

FDA Label Image

Figure6 (Valsartan06)

Chemical structure of valsartan and hydrochlorothiazide components showing a chlorinated benzene ring with sulfonamide and hydrazinyl groups attached, consistent with sulfonamide-based molecular features.*

FDA Label Image

80mg/12.5mg (Valsartan07)

Label for Valsartan and Hydrochlorothiazide tablets, USP, containing 80 mg of valsartan and 12.5 mg of hydrochlorothiazide per film-coated tablet. The label shows the NDC number 50228-147-30, indicates a bottle of 30 tablets, and is marked Rx Only. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

160mg/12.5mg (Valsartan08)

Label for Valsartan and Hydrochlorothiazide tablets, USP, strength 80 mg/12.5 mg, film-coated oral tablets. The label includes dosage storage instructions, a barcode, and the manufacturer ScieGen Pharmaceuticals, Inc. The package contains 1,000 tablets and is marked Rx only.*

FDA Label Image

160mg/25mg (Valsartan09)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg by ScieGen Pharmaceuticals, Inc. The film-coated tablets come in a container of 30 tablets, with storage instructions between 20° to 25°C and protection from moisture. The label includes the NDC number 50228-149-30 and the ScieGen Pharmaceuticals logo.*

FDA Label Image

160mg/25mg (Valsartan10)

Label for Valsartan and Hydrochlorothiazide Tablets USP 160 mg/25 mg by ScieGen Pharmaceuticals, Inc. The label indicates a package containing 1,000 film-coated tablets. It provides storage instructions to protect from moisture and specifies controlled room temperature conditions. The label includes the NDC number 50228-149-10 and states the product is Rx only.*

FDA Label Image

160mg/12.5mg (Valsartan11)

Label for Valsartan and Hydrochlorothiazide tablets, USP with strength 160 mg/12.5 mg. The film-coated oral tablets come in a 30-count package by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dosing advice, a barcode, and the NDC 50228-148-30.*

FDA Label Image

160mg/12.5mg (Valsartan12)

Label for Valsartan and Hydrochlorothiazide Tablets USP, 160 mg/12.5 mg strength. The film-coated tablet packaging contains 1,000 tablets and is labeled for oral use, prescription only. Manufactured by ScieGen Pharmaceuticals, Inc. Storage instructions and safety warnings are included on the label.*

FDA Label Image

320mg/25mg (Valsartan13)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg strength. The film-coated tablet package contains 30 tablets. The label includes storage instructions, a barcode, and the ScieGen Pharmaceuticals, Inc. logo. The product is prescription only and manufactured by ScieGen Pharmaceuticals, Hauppauge, NY.*

FDA Label Image

320mg/25mg (Valsartan14)

Label of Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, film-coated tablets. The label indicates the product contains 500 tablets, is Rx only, and is manufactured by ScieGen Pharmaceuticals, Inc. Storage instructions and a barcode are also visible.*

FDA Label Image

320mg/12.5mg (Valsartan15)

Label for Valsartan and Hydrochlorothiazide Tablets USP, 320 mg/12.5 mg, film-coated oral tablets. The package contains 30 tablets and is labeled by ScieGen Pharmaceuticals, Inc. Dosage instructions, storage information, and safety warnings are also printed on the label along with a barcode and statement 'NO VARNISH.'*

FDA Label Image

320mg/25mg (Valsartan16)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/12.5 mg by ScieGen Pharmaceuticals, INC. The film-coated tablets are supplied in a 500 count package. The label includes storage instructions, usual dosage note advising to read prescribing information, a barcode, and warnings to protect from moisture and keep out of children’s reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.